Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2019-07-12 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于申请银行综合授信及为关联方提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from 三诺生物传感股份有限公司 regarding the application for a comprehensive bank credit facility and provision of guarantees for an affiliated party (心诺健康). It includes background on previous related transactions, details of the guarantee agreements, board and independent director approvals, financial data of the guaranteed party, and the impact on the company. The content focuses on financing activities, guarantees, and credit facilities rather than financial results, management changes, or legal proceedings. It is not a full financial report or earnings release but an update on capital/financing matters. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (6158 characters) and detailed content support this classification with high confidence.
2019-07-12 Chinese
中信证券股份有限公司关于公司控股股东延长收购Trividia后续事项承诺期限的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion regarding the extension of a commitment period related to a major asset acquisition (Trividia) by the controlling shareholder of a listed company (三诺生物传感股份有限公司). It references regulatory guidelines, board and shareholder meeting approvals, and legal compliance. The document is not a full annual or interim financial report, nor is it a simple announcement. It is a formal advisory opinion on a corporate governance and compliance matter related to a major asset restructuring and shareholder commitments. This fits best under the category of Regulatory Filings (RNS) as it is a regulatory compliance document and does not contain financial statements or earnings data. The document length is about 4100 characters, which is relatively short and consistent with a regulatory filing rather than a full report.
2019-07-12 Chinese
关于召开2019年第一次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2019 first extraordinary general meeting (临时股东大会) of the company 三诺生物传感股份有限公司. It includes information about the meeting time, location, agenda items to be voted on, voting procedures (including online voting), registration details, and proxy forms. The document does not contain financial statements or results but is focused on informing shareholders about the meeting and how to participate and vote. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or other shareholder meetings. The document is not a report of voting results, nor is it a proxy solicitation or a regulatory filing. Therefore, the correct classification is AGM Information (AGM-R). The document length is sufficient and the content is substantive, supporting a high confidence score.
2019-07-12 Chinese
《公司章程》修订对照说明
Governance Information Classification · 95% confidence The document is a detailed explanation of amendments to the company's Articles of Association (公司章程修订对照说明). It includes specific changes to the company's governance rules, board responsibilities, share repurchase conditions, and other corporate governance matters. The document is issued by the company's board and is intended for shareholder approval at a general meeting. It is not a financial report, earnings release, or a simple announcement of a report publication. The content focuses on governance structure and internal rules, which aligns with the definition of Governance Information (CGR). The document length (7304 characters) and detailed content confirm it is the actual governance document, not just an announcement or summary.
2019-07-12 Chinese
第三届监事会第二十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 28th meeting of the third Supervisory Board of SanNuo Biological Sensor Co., Ltd. It details the meeting attendance, the agenda items discussed, and the voting results. The content focuses on governance matters such as approval of guarantees for related parties and extension of commitments by the controlling shareholder. There are no financial statements, earnings data, or detailed financial analysis present. The document is a formal meeting resolution announcement related to board/supervisory committee decisions, which fits the category of Board/Management Information (MANG). The document length is short (1596 characters), and it is not an announcement of a report publication but a direct disclosure of board resolutions. Therefore, the appropriate classification is MANG with high confidence.
2019-07-12 Chinese
关于取得九项医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 三诺生物传感股份有限公司 regarding the acquisition of nine medical device registration certificates issued by the Hunan Provincial Drug Administration. It lists the certificates, their validity periods, product names, classifications, and intended uses. The document emphasizes the company's innovation and the potential impact on future business but does not contain financial statements, management discussion, or detailed financial data. The length is 2328 characters, which is relatively short and the content is clearly an announcement of regulatory approvals rather than a financial report or detailed management report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-07-05 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.